nach oben

Erschienen in:

22.07.2017 | Commentary

Commentary for Special Issue of Prevention Science “Using Genetics in Prevention: Science Fiction or Science Fact?”

verfasst von: Danielle M. Dick

Erschienen in: Prevention Science | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

A growing number of prevention studies have incorporated genetic information. In this commentary, I discuss likely reasons for growing interest in this line of research and reflect on the current state of the literature. I review challenges associated with the incorporation of genotypic information into prevention studies, as well as ethical considerations associated with this line of research. I discuss areas where developmental psychologists and prevention scientists can make substantive contributions to the study of genetic predispositions, as well as areas that could benefit from closer collaborations between prevention scientists and geneticists to advance this area of study. In short, this commentary tackles the complex questions associated with what we hope to achieve by adding genetic components to prevention research and where this research is likely to lead in the future.

This technique is called LD-tagging.

Albert, D., Belsky, D. W., Crowley, D. M., Latendresse, S. J., Aliev, F., Riley, B., et al. (2015). Can genetics predict response to complex behavioral interventions? Evidence from a genetic analysis of the fast track randomized control trial. Journal of Policy Analysis and Management, 34, 497–518.CrossRefPubMedPubMedCentral

Bakermans-Kranenburg, M. J., & van Ijzendoorn, M. H. (2011). Differential susceptibility to rearing environment depending on dopamine-related genes: New evidence and a meta-analysis. Development and Psychopathology, 23, 39–52. doi:10.1017/s0954579410000635.CrossRefPubMed

Bakermans-Kranenburg, M. J., Van, I. M. H., Pijlman, F. T., Mesman, J., & Juffer, F. (2008). Experimental evidence for differential susceptibility: Dopamine D4 receptor polymorphism (DRD4 VNTR) moderates intervention effects on toddlers' externalizing behavior in a randomized controlled trial. Developmental Psychology, 44, 293–300. doi:10.1037/0012-1649.44.1.293.CrossRefPubMed

Bates, J. E., Pettit, G. S., Dodge, K. A., & Ridge, B. (1998). Interaction of temperamental resistance to control and restrictive parenting in the development of externalizing behavior. Developmental Psychology, 34, 982–995.CrossRefPubMedPubMedCentral

Beach, S. R. H., Lei, M. K., Brody, G. H., & Philibert, R. A. (2016). Prevention of early substance use mediates, and variation at SLC6A4 moderates, SAAF intervention effects on OXTR methylation. Prevention Science, 1–11. doi:10.1007/s11121-016-0709-5.

Belsky, J. (1997). Theory testing, effect-size evaluation, and differential susceptibility to rearing influence: The case of mothering and attachment. Child Development, 68, 598–600.CrossRefPubMed

Belsky, J., Bakermans-Kranenburg, M. J., & Van IJzendoorn, M. H. (2007). For better and for worse: Differential susceptibility to environmental influences. Current Directions in Psychological Science, 16, 300–304.CrossRef

Belsky, J., Jonassaint, C., Pluess, M., Stanton, M., Brummett, B., & Williams, R. (2009). Vulnerability genes or plasticity genes? Molecular Psychiatry, 14, 746–754. doi:10.1038/mp.2009.44.CrossRefPubMedPubMedCentral

Brody, G. H., Beach, S. R., Philibert, R. A., Chen, Y. F., & Murry, V. M. (2009a). Prevention effects moderate the association of 5-HTTLPR and youth risk behavior initiation: Gene x environment hypotheses tested via a randomized prevention design. Child Development, 80, 645–661. doi:10.1111/j.1467-8624.2009.01288.x.CrossRefPubMed

Brody, G. H., Chen, Y. F., Beach, S. R., Philibert, R. A., & Kogan, S. M. (2009b). Participation in a family-centered prevention program decreases genetic risk for adolescents’ risky behaviors. Pediatrics, 124, 911–917. doi:10.1542/peds.2008-3464.CrossRefPubMedPubMedCentral

Brody, G. H., Beach, S. R., Hill, K. G., Howe, G. W., Prado, G., & Fullerton, S. M. (2013). Using genetically informed, randomized prevention trials to test etiological hypotheses about child and adolescent drug use and psychopathology. American Journal of Public Health, 103, S19–S24. doi:10.2105/ajph.2012.301080.CrossRefPubMedPubMedCentral

Brody, G. H., Chen, Y. F., Beach, S. R., Kogan, S. M., Yu, T., Diclemente, R. J., et al. (2014). Differential sensitivity to prevention programming: A dopaminergic polymorphism-enhanced prevention effect on protective parenting and adolescent substance use. Health Psychology, 33, 182–191. doi:10.1037/a0031253.CrossRefPubMed

Bronfenbrenner, U. (1994). Ecological models of human development. Readings on the development of children, 2, 37–43.

Bujak, R., Struck-Lewicka, W., Markuszewski, M. J., & Kaliszan, R. (2015). Metabolomics for laboratory diagnostics. Journal of Pharmaceutical and Biomedical Analysis, 113, 108–120. doi:10.1016/j.jpba.2014.12.017.CrossRefPubMed

Burke, W., & Psaty, B. M. (2007). Personalized medicine in the era of genomics. JAMA, 298, 1682–1684. doi:10.1001/jama.298.14.1682.CrossRefPubMed

Carlson, C. S., Eberle, M. A., Rieder, M. J., Yi, Q., Kruglyak, L., & Nickerson, D. A. (2004). Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. American Journal of Human Genetics, 74, 106–120. doi:10.1086/381000.CrossRefPubMed

Caspi, A., McClay, J., Moffitt, T. E., Mill, J., Martin, J., Craig, I. W., et al. (2002). Role of genotype in the cycle of violence in maltreated children. Science, 297, 851–854. doi:10.1126/science.1072290.CrossRefPubMed

Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., et al. (2003). Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science, 301, 386–389. doi:10.1126/science.1083968.CrossRefPubMed

Christenhusz, G. M., Devriendt, K., & Dierickx, K. (2013). To tell or not to tell? A systematic review of ethical reflections on incidental findings arising in genetics contexts. European Journal of Human Genetics, 21, 248–255. doi:10.1038/ejhg.2012.130.CrossRefPubMed

Cleveland, H. H., Griffin, A. M., Wolf, P. S., Wiebe, R. P., Schlomer, G. L., Feinberg, M. E., et al. (2017). Transactions between substance use intervention, the oxytocin receptor (OXTR) gene, and peer substance use predicting youth alcohol use. Prevention Science. doi:10.1007/s11121-017-0749-5.

Collins, F. S., & Varmus, H. (2015). A new initiative on precision medicine. The New England Journal of Medicine, 372, 793–795. doi:10.1056/NEJMp1500523.CrossRefPubMedPubMedCentral

Dick, D. M., Li, T. K., Edenberg, H. J., Hesselbrock, V., Kramer, J., Kuperman, S., et al. (2004). A genome-wide screen for genes influencing conduct disorder. Molecular Psychiatry, 9, 81–86. doi:10.1038/sj.mp.4001368.CrossRefPubMed

Dick, D. M., Viken, R. J., Kaprio, J., Pulkkinen, L., & Rose, R. J. (2005). Understanding the covariation among childhood externalizing symptoms: Genetic and environmental influences on conduct disorder, attention deficit hyperactivity disorder, and oppositional defiant disorder symptoms. Journal of Abnormal Child Psychology, 33, 219–229. doi:10.1007/s10802-005-1829-8.CrossRefPubMed

Dick, D. M., Bierut, L., Hinrichs, A., Fox, L., Bucholz, K. K., Kramer, J., et al. (2006). The role of GABRA2 in risk for conduct disorder and alcohol and drug dependence across developmental stages. Behavior Genetics, 36, 577–590. doi:10.1007/s10519-005-9041-8.CrossRefPubMed

Dick, D. M., Pagan, J. L., Viken, R., Purcell, S., Kaprio, J., Pulkkinen, L., & Rose, R. J. (2007). Changing environmental influences on substance use across development. Twin Research and Human Genetics, 10, 315–326. doi:10.1375/twin.10.2.315.CrossRefPubMedPubMedCentral

Dick, D. M., Aliev, F., Wang, J. C., Saccone, S., Hinrichs, A., Bertelsen, S., et al. (2008). A systematic single nucleotide polymorphism screen to fine-map alcohol dependence genes on chromosome 7 identifies association with a novel susceptibility gene ACN9. Biological Psychiatry, 63, 1047–1053. doi:10.1016/j.biopsych.2007.11.005.CrossRefPubMed

Dick, D. M., Riley, B., & Latendresse, S. (2011). Incorporating genetics into your studies: A guide for social scientists. Frontiers in Psychiatry, 2(17). doi:10.3389/fpsyt.2011.00017.

Dick, D. M., Barr, P., Cho, S.B., Cooke, M., Kuo, S., Lewis, T., Neale, Z., Salvatore, J., Savage, J., Su, J. (2017). Post-GWAS in psychiatric genetics: A developmental perspective on the “other” next steps. Under review.

Dishion, T. J., Brennan, L. M., Shaw, D. S., McEachern, A. D., Wilson, M. N., & Jo, B. (2014). Prevention of problem behavior through annual family check-ups in early childhood: Intervention effects from home to early elementary school. Journal of Abnormal Child Psychology, 42, 343–354. doi:10.1007/s10802-013-9768-2.CrossRefPubMedPubMedCentral

Farrell, M. S., Werge, T., Sklar, P., Owen, M. J., Ophoff, R. A., O’Donovan, M. C., et al. (2015). Evaluating historical candidate genes for schizophrenia. Molecular Psychiatry, 20, 555–562. doi:10.1038/mp.2015.16.CrossRefPubMedPubMedCentral

Feero, W. G., & Guttmacher, A. E. (2014). Genomics, personalized medicine, and pediatrics. Academic Pediatrics, 14, 14–22. doi:10.1016/j.acap.2013.06.008.CrossRefPubMedPubMedCentral

Friedman, N., & Rando, O. J. (2015). Epigenomics and the structure of the living genome. Genome Research, 25, 1482–1490. doi:10.1101/gr.190165.115.CrossRefPubMedPubMedCentral

Glenn, A. L., Lochman, J. E., Dishion, T., Powell, N. P., Boxmeyer, C., & Qu, L. (2017). Oxytocin receptor gene variant interacts with intervention delivery format in predicting intervention outcomes for youth with conduct problems. Prevention Science. doi:10.1007/s11121-017-0777-1.

Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., et al. (2013). ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine, 15, 565–574. doi:10.1038/gim.2013.73.CrossRefPubMedPubMedCentral

Guo, G., Wilhelmsen, K., & Hamilton, N. (2007). Gene–lifecourse interaction for alcohol consumption in adolescence and young adulthood: Five monoamine genes. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 144, 417–423.CrossRef

Guttmacher, A. E., & Collins, F. S. (2003). Welcome to the genomic era. The New England Journal of Medicine, 349, 996–998. doi:10.1056/NEJMe038132.CrossRefPubMed

Guttmacher, A. E., Porteous, M. E., & McInerney, J. D. (2007). Educating health-care professionals about genetics and genomics. Nature Reviews. Genetics, 8, 151–157. doi:10.1038/nrg2007.CrossRefPubMed

Hendrickson, B. C., Donohoe, C., Akmaev, V. R., Sugarman, E. A., Labrousse, P., Boguslavskiy, L., et al. (2009). Differences in SMN1 allele frequencies among ethnic groups within North America. Journal of Medical Genetics, 46, 641–644. doi:10.1136/jmg.2009.066969.CrossRefPubMedPubMedCentral

Hettema, J. M., Neale, M. C., & Kendler, K. S. (2001). A review and meta-analysis of the genetic epidemiology of anxiety disorders. The American Journal of Psychiatry, 158, 1568–1578. doi:10.1176/appi.ajp.158.10.1568.CrossRefPubMed

Humphery-Smith, I. (2015). The 20th anniversary of proteomics and some of its origins. Proteomics, 15, 1773–1776. doi:10.1002/pmic.201400582.CrossRefPubMed

Irons, D. E., Iacono, W. G., Oetting, W. S., & McGue, M. (2012). Developmental trajectory and environmental moderation of the effect of ALDH2 polymorphism on alcohol use. Alcoholism, Clinical and Experimental Research, 36, 1882–1891. doi:10.1111/j.1530-0277.2012.01809.x.CrossRefPubMedPubMedCentral

Kessler, R. C., Crum, R. M., Warner, L. A., Nelson, C. B., Schulenberg, J., & Anthony, J. C. (1997). Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Archives of General Psychiatry, 54, 313–321.CrossRefPubMed

Latendresse, S. J., Musci, R., & Maher, B. S. (2017). Critical issues in the inclusion of genetic and epigenetic information in prevention and intervention trials. Prevention Science. doi:10.1007/s11121-017-0785-1.

Leve, L. D., Neiderhiser, J. M., Harold, G. T., Natsuaki, M. N., Bohannan, B. J., & Cresko, W. A. (2017). Naturalistic experimental designs as tools for understanding the role of genes and the environment in prevention research. Prevention Science. doi:10.1007/s11121-017-0746-8.

Li, J. J., Cho, S. B., Salvatore, J. E., Edenberg, H. J., Agrawal, A., Chorlian, D. B., et al. (2017). The impact of peer substance use and polygenic risk on trajectories of heavy episodic drinking across adolescence and emerging adulthood. Alcoholism, Clinical and Experimental Research, 41, 65–75. doi:10.1111/acer.13282.CrossRefPubMed

Maher, B. S., Latendresse, S., & Vanyukov, M. M. (2016). Informing prevention and intervention policy using genetic studies of resistance. Prevention Science, 1–9. doi:10.1007/s11121-016-0730-8.

McCarthy, S., Das, S., Kretzschmar, W., Delaneau, O., Wood, A. R., Teumer, A., et al., the Haplotype Reference. (2016). A reference panel of 64,976 haplotypes for genotype imputation. Nature Genetics, 48, 1279–1283. doi:10.1038/ng.3643.

McDonald, D., Birmingham, A., & Knight, R. (2015). Context and the human microbiome. Microbiome, 3, 52. doi:10.1186/s40168-015-0117-2.CrossRefPubMedPubMedCentral

Musci, R. J., Fairman, B., Masyn, K. E., Uhl, G., Maher, B., Sisto, D. Y., et al. (2016). Polygenic score × intervention moderation: An application of discrete-time survival analysis to model the timing of first marijuana use among urban youth. Prevention Science, 1–9. doi:10.1007/s11121-016-0729-1.

O’Donovan, M. C. (2015). What have we learned from the Psychiatric Genomics Consortium. World Psychiatry, 14, 291–293. doi:10.1002/wps.20270.CrossRefPubMedPubMedCentral

Okbay, A., Beauchamp, J. P., Fontana, M. A., Lee, J. J., Pers, T. H., Rietveld, C. A., et al. (2016). Genome-wide association study identifies 74 loci associated with educational attainment. Nature, 533, 539–542. doi:10.1038/nature17671.CrossRefPubMedPubMedCentral

Pappa, I., St Pourcain, B., Benke, K., Cavadino, A., Hakulinen, C., Nivard, M. G., et al. (2016). A genome-wide approach to children’s aggressive behavior: The EAGLE consortium. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 171, 562–572.CrossRef

Ripke, S., Wray, N. R., Lewis, C. M., Hamilton, S. P., Weissman, M. M., Breen, G., et al. (2013). A mega-analysis of genome-wide association studies for major depressive disorder. Molecular Psychiatry, 18, 497–511. doi:10.1038/mp.2012.21.CrossRefPubMed

Russell, M. A., Schlomer, G. L., Cleveland, H. H., Feinberg, M. E., Greenberg, M. T., Spoth, R. L., et al. (2017). PROSPER intervention effects on adolescents' alcohol misuse vary by GABRA2 genotype and age. Prevention Science. doi:10.1007/s11121-017-0751-y.

Salvatore, J. E., Aliev, F., Edwards, A. C., Evans, D. M., Macleod, J., Hickman, M., et al. (2014). Polygenic scores predict alcohol problems in an independent sample and show moderation by the environment. Genes (Basel), 5, 330–346. doi:10.3390/genes5020330.CrossRef

Salvatore, J. E., Aliev, F., Bucholz, K., Agrawal, A., Hesselbrock, V., Hesselbrock, M., et al. (2015). Polygenic risk for externalizing disorders: Gene-by-development and gene-by-environment effects in adolescents and young adults. Clinical Psychological Science: A Journal of the Association for Psychological Science, 3, 189–201. doi:10.1177/2167702614534211.CrossRef

Schizophrenia Working Group of the Psychiatric Genomics Consortium. (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature, 511, 421–427. doi:10.1038/nature13595.CrossRefPubMedCentral

Schlaepfer, I. R., Hoft, N. R., Collins, A. C., Corley, R. P., Hewitt, J. K., Hopfer, C. J., et al. (2008). The CHRNA5/A3/B4 gene cluster variability as an important determinant of early alcohol and tobacco initiation in young adults. Biological Psychiatry, 63, 1039–1046. doi:10.1016/j.biopsych.2007.10.024.CrossRefPubMed

The Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. (2011). Genome-wide association study identifies five new schizophrenia loci. Nature Genetics., 43, 969–976. doi:10.1038/ng.940.CrossRef

Turley, P., Walters, R. K., Maghzian, O., Okbay, A., Lee, J. J., Fontana, M. A., . . . Benjamin, D. J. (2017). MTAG: Multi-trait analysis of GWAS. bioRxiv.

Walsh, C. G., Ribeiro, J. D., & Franklin, J. C. (2017). Predicting risk of suicide attempts over time through machine learning. Clinical Psychological Science, 5, 457–469.CrossRef

Webb, B. T., Edwards, A. C., Wolen, A. R., Salvatore, J. E., Aliev, F., Riley, B. P., et al. (2017). Molecular genetic influences on normative and problematic alcohol use in a population-based sample of college students. Frontiers in Genetics, 8. doi:10.3389/fgene.2017.00030.

Wolf, S. M., Lawrenz, F. P., Nelson, C. A., Kahn, J. P., Cho, M. K., Clayton, E. W., et al. (2008). Managing incidental findings in human subjects research: Analysis and recommendations. The Journal of Law, Medicine & Ethics, 36, 219–248, 211. doi:10.1111/j.1748-720X.2008.00266.x.CrossRef

Wood, A. R., Esko, T., Yang, J., Vedantam, S., Pers, T. H., Gustafsson, S., et al. (2014). Defining the role of common variation in the genomic and biological architecture of adult human height. Nature Genetics, 46, 1173–1186. doi:10.1038/ng.3097.CrossRefPubMedPubMedCentral

Zheng, Y., Albert, D., McMahon, R. J., Dodge, K., & Dick, D. (2016). Glucocorticoid receptor (NR3C1) gene polymorphism moderate intervention effects on the developmental trajectory of African-American adolescent alcohol abuse. Prevention Science, 1–11. doi:10.1007/s11121-016-0726-4.

Titel: Commentary for Special Issue of Prevention Science “Using Genetics in Prevention: Science Fiction or Science Fact?”
verfasst von: Danielle M. Dick
Publikationsdatum: 22.07.2017
Verlag: Springer US
Erschienen in: Prevention Science / Ausgabe 1/2018
Print ISSN: 1389-4986
Elektronische ISSN: 1573-6695
DOI: https://doi.org/10.1007/s11121-017-0828-7

Transactions Between Substance Use Intervention, the Oxytocin Receptor (OXTR) Gene, and Peer Substance Use Predicting Youth Alcohol Use

Glucocorticoid Receptor (NR3C1) Gene Polymorphism Moderate Intervention Effects on the Developmental Trajectory of African-American Adolescent Alcohol Abuse

Polygenic Score × Intervention Moderation: an Application of Discrete-Time Survival Analysis to Model the Timing of First Marijuana Use Among Urban Youth

Springer Medizin

Commentary for Special Issue of Prevention Science “Using Genetics in Prevention: Science Fiction or Science Fact?”

Abstract

Weitere Artikel der Ausgabe 1/2018

Transactions Between Substance Use Intervention, the Oxytocin Receptor (OXTR) Gene, and Peer Substance Use Predicting Youth Alcohol Use

Glucocorticoid Receptor (NR3C1) Gene Polymorphism Moderate Intervention Effects on the Developmental Trajectory of African-American Adolescent Alcohol Abuse

Polygenic Score × Intervention Moderation: an Application of Discrete-Time Survival Analysis to Model the Timing of First Marijuana Use Among Urban Youth

Oxytocin Receptor Gene Variant Interacts with Intervention Delivery Format in Predicting Intervention Outcomes for Youth with Conduct Problems

Prevention of Early Substance Use Mediates, and Variation at SLC6A4 Moderates, SAAF Intervention Effects on OXTR Methylation

Critical Issues in the Inclusion of Genetic and Epigenetic Information in Prevention and Intervention Trials

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Transactions Between Substance Use Intervention, the Oxytocin Receptor (OXTR) Gene, and Peer Substance Use Predicting Youth Alcohol Use

Glucocorticoid Receptor (NR3C1) Gene Polymorphism Moderate Intervention Effects on the Developmental Trajectory of African-American Adolescent Alcohol Abuse

Polygenic Score × Intervention Moderation: an Application of Discrete-Time Survival Analysis to Model the Timing of First Marijuana Use Among Urban Youth

Oxytocin Receptor Gene Variant Interacts with Intervention Delivery Format in Predicting Intervention Outcomes for Youth with Conduct Problems

Prevention of Early Substance Use Mediates, and Variation at SLC6A4 Moderates, SAAF Intervention Effects on OXTR Methylation

Critical Issues in the Inclusion of Genetic and Epigenetic Information in Prevention and Intervention Trials